To meet working capital needs associated with domestic sales of Akougo\u00ae, SanBio expanded its commitment line with Resona Bank and increased the borrowing facility to 5,000 million yen. The previous 1,000 million yen facility terminated on the same date. The impact on consolidated earnings guidance for the fiscal year ending January 2027 is minimal.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4592","jir_company_name":"SanBio Company Limited","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-30","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/4592-20261030-01.pdf","jir_short_summary":"To meet working capital needs associated with domestic sales of Akougo\u00ae, SanBio expanded its commitment line with Resona Bank and increased the borrowing facility to 5,000 million yen. The previous 1,000 million yen facility terminated on the same date. The impact on consolidated earnings guidance for the fiscal year ending January 2027 is minimal.","jir_summary":"### Overview of Capital Policy\nSanBio refreshed its existing commitment line with Resona Bank and expanded the borrowing facility to 5,000 million yen. The new agreement aims to secure working capital related to the domestic sales of Akougo\u00ae, allowing funds previously raised through equity issuance to be redirected to growth investments, thereby strengthening the financial base and increasing funding flexibility. The previous 1,000 million yen facility terminated as of the execution date of this agreement.\n\n### Outlook and Impact\nThe impact on consolidated earnings guidance for the fiscal year ending January 2027 is considered minimal, and the arrangement improves funding stability to support business development and scale-up following the launch of Akougo\u00ae sales. The company will continue to expand its business through regional deployment and both manufacturing and sales operations.","jir_financial_highlights":"Commitment Line Amount: 5,000 million yen (Expanded from previous 1,000 million yen facility)\nAgreement Date: October 30, 2026 (New agreement executed)\nAgreement Term: October 30, 2028 (New agreement term)","jir_category":"","jir_hashtags":"#SanBio, #CapitalPolicy, #CommitmentLineExpansion","jir_key_figures":"Key Figure 1: Commitment Line Amount 5,000 million yen\nKey Figure 2: Agreement Term October 30, 2028\nKey Figure 3: Previous facility of 1,000 million yen terminated as of the execution date of this agreement","jir_meta_title":"SanBio Announces Expansion of Funding Facility\uff5cOctober 2026","jir_meta_description":"SanBio expanded its commitment line with Resona Bank to a 5,000 million yen borrowing facility, terminating the previous 1,000 million yen facility. The move secures working capital for domestic sales of Akougo\u00ae and strengthens the company's financial base.","jir_og_title":"SanBio Expands Borrowing Facility to 5,000 million yen\uff5cOctober 2026","jir_og_description":"SanBio strengthens working capital availability under a new agreement with Resona Bank to support sales of Akougo\u00ae and stabilize its financial base.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9416,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"capital_policy","footnotes":""},"sector":[],"importance":[],"class_list":["post-138902","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n